K. Delavigne

1.4k total citations
20 papers, 390 citations indexed

About

K. Delavigne is a scholar working on Hematology, Genetics and Epidemiology. According to data from OpenAlex, K. Delavigne has authored 20 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Genetics and 5 papers in Epidemiology. Recurrent topics in K. Delavigne's work include Platelet Disorders and Treatments (4 papers), Eosinophilic Disorders and Syndromes (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). K. Delavigne is often cited by papers focused on Platelet Disorders and Treatments (4 papers), Eosinophilic Disorders and Syndromes (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). K. Delavigne collaborates with scholars based in France and Italy. K. Delavigne's co-authors include Ronan Le Calloch, Laëtitia Souchet, Brigitte Dreyfus, Caroline Dartigeas, Loïc Ysebaert, David Ghez, Kamel Laribi, Charles Herbaux, Marion Malphettes and Franciane Paul and has published in prestigious journals such as Blood, Clinical Infectious Diseases and British Journal of Dermatology.

In The Last Decade

K. Delavigne

18 papers receiving 387 citations

Peers

K. Delavigne
Ronan Le Calloch France
Yuichiro Nawa Japan
John L. Snow United States
Smeeta Gajendra India
F Cottenot France
D I Marks United Kingdom
J.P. Merlio France
Romain Lévy France
Shunichiro Takezaki Japan
Maki Hagihara Japan
Ronan Le Calloch France
K. Delavigne
Citations per year, relative to K. Delavigne K. Delavigne (= 1×) peers Ronan Le Calloch

Countries citing papers authored by K. Delavigne

Since Specialization
Citations

This map shows the geographic impact of K. Delavigne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Delavigne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Delavigne more than expected).

Fields of papers citing papers by K. Delavigne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Delavigne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Delavigne. The network helps show where K. Delavigne may publish in the future.

Co-authorship network of co-authors of K. Delavigne

This figure shows the co-authorship network connecting the top 25 collaborators of K. Delavigne. A scholar is included among the top collaborators of K. Delavigne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Delavigne. K. Delavigne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guillon, Benoît, V. Sibaud, K. Delavigne, et al.. (2025). Case Report: Acral vasculitis induced by Immune Checkpoint Inhibitors: a case series and literature review. Frontiers in Oncology. 15. 1537825–1537825.
2.
Sibaud, V., A. Maria, Emmanuelle Uro‐Coste, et al.. (2025). Immune checkpoint inhibitor-related eosinophilic fasciitis: 3 case reports with literature review. La Revue de Médecine Interne. 46(7). 377–385.
3.
4.
Sibaud, V., Cécile Pagès, K. Delavigne, et al.. (2024). Revue des atteintes dermatologiques atypiques et/ou systémiques en lien avec les inhibiteurs de checkpoints immunologiques. La Revue de Médecine Interne. 46(7). 369–376. 1 indexed citations
5.
Sibaud, V., et al.. (2024). Immune checkpoint inhibitor-related acquired amegakaryocytosis thrombocytopenia: a case report and literature review. Frontiers in Oncology. 14. 1353896–1353896. 1 indexed citations
6.
Maria, A., et al.. (2024). Fasciite à éosinophiles induite par les inhibiteurs du checkpoint immunologique : série de cas et revue de la littérature. La Revue de Médecine Interne. 45. A94–A95. 1 indexed citations
7.
Martin‐Blondel, Guillaume, Stéphanie Ruiz, Marlène Murris, et al.. (2020). Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics. Clinical Infectious Diseases. 71(11). 2962–2964. 6 indexed citations
8.
Comont, Thibault, K. Delavigne, Pierre Cougoul, et al.. (2019). Prise en charge des syndromes myélodysplasiques en 2019 : mise au point. La Revue de Médecine Interne. 40(9). 581–589. 1 indexed citations
9.
Franchet, Camille, K. Delavigne, Eva Jouve, et al.. (2019). Breast pyoderma gangrenosum: A rare postoperative complication of antiphospholipid antibody syndrome. The Breast Journal. 25(3). 498–499. 6 indexed citations
10.
Ghez, David, Caroline Protin, Marine Baron, et al.. (2018). Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib. Blood. 131(17). 1955–1959. 205 indexed citations
11.
Comont, Thibault, et al.. (2017). Thrombopénie immunologique en phase aiguë au cours d’une crise vaso-occlusive chez une patiente drépanocytaire : une prise en charge complexe. La Revue de Médecine Interne. 38. A217–A218. 1 indexed citations
12.
Comont, Thibault, Guillaume Moulis, K. Delavigne, et al.. (2016). Effect of Pregnancy in Women with a History of Primary Immune Thrombocytopenia Considered As Cured. Blood. 128(22). 2552–2552. 1 indexed citations
13.
Delavigne, K., Sarah Bertoli, Jill Corre, et al.. (2013). Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy. Haematologica. 99(3). 474–480. 58 indexed citations
14.
15.
Prévôt, Grégoire, K. Delavigne, Pierre Cougoul, et al.. (2011). 186 Interstitial lung disease: Uncommon but potentially severe effect of hypomethylating agents. Leukemia Research. 35. S73–S73. 1 indexed citations
16.
Moulis, Guillaume, et al.. (2010). Des céphalées chroniques. La Revue de Médecine Interne. 32(1). 46–47. 1 indexed citations
17.
Livideanu, C. Bulaï, Jérémie Jegu, C. Paul, et al.. (2010). Prevalence and prognostic value of cutaneous manifestations in patients with myelodysplastic syndrome. Journal of the European Academy of Dermatology and Venereology. 24(10). 1171–1175. 27 indexed citations
18.
Marie, I., Olivier Benvéniste, K. Delavigne, et al.. (2009). Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody. British Journal of Dermatology. 162(2). 337–344. 71 indexed citations
19.
Madaule, S., et al.. (2008). Le paradoxe des fièvres prolongées inexpliquées. Médecine Nucléaire. 32(3). 161–172. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronan Le Calloch Breakdown of academic impact, for papers by Yuichiro Nawa Breakdown of academic impact, for papers by John L. Snow Breakdown of academic impact, for papers by Smeeta Gajendra Breakdown of academic impact, for papers by F Cottenot Breakdown of academic impact, for papers by D I Marks Breakdown of academic impact, for papers by J.P. Merlio Breakdown of academic impact, for papers by Romain Lévy Breakdown of academic impact, for papers by Shunichiro Takezaki Breakdown of academic impact, for papers by Maki Hagihara
Rankless by CCL
2026